Mr. Yong-Feng Cheng | Organic Chemistry | Best Researcher Award

Mr. Yong-Feng Cheng | Organic Chemistry | Best Researcher Award

Mr. Yong-Feng Cheng , Organic Chemistry, Anhui Normal University, China

Dr. Yong-Feng Cheng is an Associate Professor at the School of Chemistry and Materials Science, Anhui Normal University, China. He is a leading researcher in the field of radical chemistry and enantioselective catalysis. After earning his Ph.D. in Organic Chemistry from Nankai University, he pursued postdoctoral and faculty roles at the Southern University of Science and Technology, where he made significant contributions to copper-catalyzed asymmetric transformations. Dr. Cheng’s research, published in prestigious journals such as Nature Chemistry, JACS, and Nature Catalysis, emphasizes radical-based bond-forming reactions and novel catalytic systems. With a solid background in pharmacy and pharmaceutical analysis, he bridges organic synthesis with potential bioactive molecule development. His work is characterized by mechanistic insight, innovation in catalyst design, and collaboration with renowned scientists like Prof. X. Liu and Prof. K.N. Houk. Dr. Cheng continues to push boundaries in modern synthetic chemistry, mentoring students and contributing to cutting-edge discoveries.

Professional Profile :         

Orcid

Scopus  

Summary of Suitability for Award:

Assoc. Prof. Yong-Feng Cheng stands out as a highly suitable candidate for the “Best Researcher Award” . Based on his exceptional publication record, breakthrough contributions to enantioselective radical chemistry, rapid career advancement, and international collaboration, Assoc. Prof. Yong-Feng Cheng is highly deserving of the “Best Researcher Award.” His work reflects a balance of innovation, depth, and scientific rigor, and he has already made a significant mark in modern synthetic chemistry. Granting him this recognition would not only honor a deserving candidate but also inspire broader excellence in chemical sciences.

🎓Education:

Yong-Feng Cheng began his academic journey with a Bachelor’s degree in Pharmacy from Wannan Medical College (2005–2009). Motivated by a strong interest in the analytical and chemical aspects of drug development, he pursued a Master of Science in Pharmaceutical Analysis at Tianjin University of Traditional Chinese Medicine (2009–2012). His growing passion for organic synthesis led him to Nankai University, where he earned his Ph.D. in Organic Chemistry (2012–2015). At Nankai, he specialized in developing synthetic methodologies and advanced radical transformations. His doctoral training laid a solid foundation for his future work in radical catalysis. With this multidisciplinary education—spanning pharmacy, analytical science, and organic chemistry—Dr. Cheng brings a uniquely integrated perspective to the development of functional molecules and asymmetric synthesis. His academic background enables him to innovate at the intersection of fundamental chemistry and potential therapeutic applications.

🏢Work Experience:

Dr. Yong-Feng Cheng has steadily advanced through competitive academic roles in China’s premier institutions. From 2016 to 2018, he worked as a postdoctoral fellow at the Southern University of Science and Technology (SUSTech), collaborating on pioneering research in enantioselective radical transformations. Recognized for his innovative approach, he was promoted to Research Assistant Professor at SUSTech (2018–2022), where he co-authored several high-impact papers and contributed significantly to catalyst development. In 2023, he joined Anhui Normal University as an Associate Professor in the School of Chemistry and Materials Science. His current role involves leading a research group focused on asymmetric catalysis, mentoring graduate students, and securing national research grants. With a blend of research acumen and teaching excellence, Dr. Cheng continues to shape the future of synthetic chemistry, integrating his deep understanding of radicals, catalysis, and reaction mechanisms across disciplines.

🏅Awards: 

While the specific awards and honors of Dr. Yong-Feng Cheng are not explicitly listed, his track record of publishing in journals like Nature Chemistry, JACS, and Angewandte Chemie reflects high recognition in the international scientific community. Being co-first and corresponding author in several high-impact papers demonstrates peer acknowledgment of his leading role in radical catalysis. His research collaborations with globally renowned scientists like Prof. K.N. Houk and Prof. X. Liu further validate his standing as an innovative researcher. His rapid career progression—from Ph.D. to Associate Professor in under a decade—is itself a testimony to his scientific excellence. He has likely received institutional recognition for teaching and research performance and may have earned national-level research grants or young scientist accolades. As his work continues to draw citations and attention, more formal honors are anticipated in the near future.

🔬Research Focus:

Dr. Yong-Feng Cheng’s research is centered on enantioselective radical transformations, with a focus on copper-catalyzed asymmetric reactions. His work explores the interface of Organic chemistry and catalysis, developing novel methodologies for constructing C–O, S–O, and C–C bonds with high stereo control. His synthetic strategies employ innovative ligand systems and cooperative catalysis to achieve de- symmetrization and functionalization of otherwise inert molecules. Dr. Cheng has contributed significantly to the design of catalytic systems that enable precise manipulation of reactive radical intermediates, with potential applications in pharmaceuticals, agrochemicals, and material science. He is particularly interested in mechanistic insights, transition-state modeling, and computational collaboration to understand catalytic pathways. With a strong background in both pharmacy and organic synthesis, Dr. Cheng’s research is both methodologically rigorous and application-oriented. His group continues to develop sustainable and scalable reactions for asymmetric synthesis, including redox-triggered transformations and metal-catalyzed coupling strategies.

Publication Top Notes:

1. A P‐nucleophile Interrupted Seyferth‐Gilbert Reaction

2. Synthesis of Axially Chiral Vinyl Halides via Cu(I)-Catalyzed Enantioselective Radical 1,2-Halofunctionalization of Terminal Alkynes

3. Cu(I)-Catalyzed Chemo- and Enantioselective Desymmetrizing C–O Bond Coupling of Acyl Radicals

4. Cu-Catalyzed Enantioselective Radical Heteroatomic S–O Cross-Coupling

5. Catalytic Enantioselective Desymmetrizing Functionalization of Alkyl Radicals via Cu(I)/CPA Cooperative Catalysis

6. Desymmetrization of Unactivated Bis-Alkenes via Chiral Brønsted Acid-Catalyzed Hydroamination

7. Achiral Pyridine Ligand-Enabled Enantioselective Radical Oxytrifluoromethylation of Alkenes with Alcohols

8. Synthesis of γ-Lactams by Mild, o-Benzoquinone-Induced Oxidation of Pyrrolidines Containing Oxidation-Sensitive Functional Groups

9. Redox-Triggered α-C–H Functionalization of Pyrrolidines: Synthesis of Unsymmetrically 2,5-Disubstituted Pyrrolidines

10. A New Practical Approach Towards the Synthesis of Unsymmetric and Symmetric 1,10-Phenanthroline Derivatives at Room Temperature

 

Dr. Hongjian Qin | Organic Chemistry | Best Researcher Award

Dr. Hongjian Qin | Organic Chemistry | Best Researcher Award

Dr. Hongjian Qin , Shanghai Institute of Materia Medica, CAS , China

Dr. Hongjian Qin is an accomplished researcher in sustainable and green chemistry, with expertise in drug process development and medicinal administration. He earned his Ph.D. in Organic Chemistry from the Chinese Academy of Sciences, being recognized as an Excellent Graduate in 2024. Dr. Hongjian Qin’s contributions to the field span over three years, emphasizing environmentally friendly pharmaceutical synthesis and active pharmaceutical ingredient (API) development. Currently serving as Research Director at Topharman Company Limited, he continues to advance innovative solutions in drug development. His work includes mentoring students, enhancing resource recovery, and participating in COVID-19 research. With numerous impactful publications, Dr. Hongjian Qin is a dedicated professional committed to promoting sustainability and advancing solutions for global environmental challenges.

Professional Profile:

Scopus 

Summary of Suitability for Award:

Dr. Hongjian Qin is an exemplary candidate for the “Best Researcher Awards,” with a distinguished career in sustainable and green chemistry. His pioneering research in eco-friendly pharmaceutical synthesis has significantly contributed to reducing industrial waste and enhancing process efficiency, aligning with global sustainability objectives. Dr. Hongjian Qin’s innovative work on ligand-free catalysis, large-scale API production, and impurity profiling reflects his expertise in developing practical solutions for complex challenges in organic chemistry and medicinal chemistry. Dr. Hongjian Qin’s research excellence, innovative contributions, and global impact make him a highly deserving candidate for the “Best Researcher Awards.” His work not only addresses critical scientific challenges but also fosters sustainable practices in drug development, making a lasting impact on both academia and industry.

🎓Education:

Dr. Hongjian Qin holds a Ph.D. in Organic Chemistry from the Chinese Academy of Sciences , specializing in process development of drug substances and medicinal administration. His doctoral work was conducted at the Key Laboratory of Plant Resources and Chemistry in Arid Regions, showcasing expertise in sustainable pharmaceutical synthesis. He completed a Master of Engineering in Organic Chemistry from Guangxi University, focusing on the process development of drug substances. Dr. Qin’s academic journey began with a Bachelor of Science in Organic Chemistry from Guangxi University . His educational foundation combines rigorous theoretical knowledge with practical applications, preparing him to address complex challenges in green and sustainable chemistry.

🏢Work Experience:

Dr. Hongjian Qin’s professional journey spans over a decade, focusing on pharmaceutical synthesis and sustainable chemistry. As Research Director at Topharman Company Limited (2024–present), he spearheads innovations in active pharmaceutical ingredients (APIs) and emphasizes good manufacturing practices (GMP). Previously, as a Research Assistant at the Shanghai Institute of Materia Medica (2021–2024), he supported COVID-19 research projects, trained students, and enhanced pharmaceutical waste recovery techniques. At the Xinjiang Engineering Research Centre for Key Technologies and Processes of Ethnomedicine (2015–2021), Dr. Hongjian Qin led projects on sustainable API production and industrial resource recovery. His experiences reflect a blend of academic research and industrial application, driving advancements in pharmaceutical science.

🏅Awards: 

Dr. Hongjian Qin has received numerous accolades for his contributions to sustainable chemistry. He was honored as an Excellent Graduate in 2024 by the University of Chinese Academy of Sciences for his outstanding academic achievements during his Ph.D. studies. His work on sustainable pharmaceutical synthesis earned him recognition at various national and international conferences. Dr. Hongjian Qin has been instrumental in developing innovative processes for drug substances, garnering appreciation from industrial partners. Additionally, his mentorship roles and administrative contributions at research institutions have been commended, underscoring his commitment to advancing science and education.

🔬Research Focus:

Dr. Hongjian Qin’s research focuses on sustainable and green chemistry, particularly in the process development of drug substances. He has worked extensively on optimizing synthesis methods for pharmaceutical intermediates, reducing waste, and improving efficiency in drug manufacturing. His innovative approaches emphasize the use of eco-friendly reagents and catalysts, aligning with global sustainability goals. His recent work includes developing ligand-free copper-catalyzed cyclization methods, novel iron-catalyzed cross-coupling reactions, and efficient large-scale processes for active pharmaceutical ingredients (APIs). Dr. Hongjian Qin is dedicated to advancing environmentally responsible techniques in pharmaceutical synthesis, ensuring both industrial viability and ecological preservation.

Publication Top Notes:

1. Direct Esterification of Amides by the Dimethylsulfate-Mediated Activation of Amide C–N Bonds

Authors: Qin, H.; Han, Z.; Bonku, E.M.; Shen, J.; Aisa, H.A.

Year: 2024

Citations: 0

2. An Alternative Approach to Synthesize Sildenafil via Improved Copper-Catalyzed Cyclization

Authors: Odilov, A.; Gong, X.; Qin, H.; Yang, F.; Shen, J.

Year: 2024

Citations: 0

3. Impurity Study of Tecovirimat (Open Access)

Authors: Bonku, E.M.; Qin, H.; Odilov, A.; Wang, X.; Shen, J.

Year: 2024

Citations: 1

4. Improved and Ligand-Free Copper-Catalyzed Cyclization for an Efficient Synthesis of Benzimidazoles from o-Bromoarylamine and Nitriles (Open Access)

Authors: Bonku, E.M.; Qin, H.; Odilov, A.; Aisa, H.A.; Shen, J.

Year: 2024

Citations: 2

5. Direct Reductive N-Alkylation of Amines with Carboxylic Esters

Authors: Zhang, Y.; Bonku, E.M.; Yang, X.; Shen, J.; Qin, H.

Year: 2024 (In Press)

Citations: 0

6. Iron-Catalyzed Cross-Coupling Reactions of Alkyl Grignard Reagents with Alkenyl Carbonate

Authors: Qin, H.; Yang, X.; Mintah Bonku, E.; Shen, J.; Akber Aisa, H.

Year: 2024 (In Press)

Citations: 0

7. A Review of the Synthetic Strategies Toward the Antiviral Drug Tecovirimat (Review Article)

Authors: Bonku, E.M.; Qin, H.; Odilov, A.; Zhu, F.; Shen, J.

Year: 2024 (In Press)

Citations: 0

8. An Improved Iodine-Catalyzed Aromatization Reaction and Its Application in the Synthesis of a Key Intermediate of Cannabidiol

Authors: Abduahadi, S.; Bonku, E.M.; Qin, H.; Aisa, H.A.; Shen, J.

Year: 2024 (In Press)

Citations: 0

9. Optimized Synthesis of the Key Intermediate of Telmisartan via the Cyclization of 2-Bromoarylamine with n-Butyronitrile

Authors: Qin, H.; Mintah Bonku, E.; Odilov, A.; Zhu, F.; Aisa, H.A.

Year: 2023

Citations: 1

10. Efficient Large-Scale Process for Tecovirimat via Reactive Distillation for the Preparation of Cycloheptatriene

Authors: Bonku, E.M.; Qin, H.; Odilov, A.; Guma, S.D.; Shen, J.

Year: 2023

Citations: 4

 

 

 

 

 

Prof . Dmitry Dar’in | Organic Chemistry Award | Best Researcher Award

Prof . Dmitry Dar’in | Organic Chemistry Award | Best Researcher Award

Prof . Dmitry Dar’in  , Saint Petersburg State University, Institute of Chemistry, Russia 

Prof. Dmitry Dar’in is a distinguished chemist at the Institute of Chemistry, Saint Petersburg State University, with over 20 years of academic and research expertise. He is widely recognized for his work in heterocyclic chemistry and organic synthesis, actively supervising more than 20 graduate students. Prof. Dar’in has significantly advanced research in the synthesis of polysubstituted lactams and diazo compounds, expanding the boundaries of diazo chemistry and multicomponent reactions. With a robust publication record, including 236 Scopus-indexed articles, he has made remarkable contributions to targeted protein degradation, antitubercular agents, and trace amine-associated receptor studies. His dedication to scientific collaboration is evident in his partnerships with top international researchers, including Prof. Ewgenij Proschak, Prof. Saeed Balalaie, and Dr. Marcus D. Hartmann. He also serves as a Guest Editor for the journal Molecules on the “Diazo Chemistry” special issue. Prof. Dar’in is an influential figure in modern chemistry, continually driving innovation and education.

Professional Profile:

Scopus

Orcid

Summary of Suitability for Award:

Prof. Dmitry Dar’in is exceptionally suited for the “Best Researcher Award” due to his impactful contributions to the fields of diazo chemistry, heterocyclic compounds, and multicomponent reactions. With over 20 years of experience and an extensive portfolio of 236 Scopus-indexed publications, his work has significantly influenced organic synthesis, particularly in developing innovative methodologies for diazo compound synthesis in aqueous media and expanding the Castagnoli-Cushman reaction’s applications. His high citation index (h-index of 23) reflects the relevance and quality of his research contributions, demonstrating a consistent commitment to advancing chemical science.

🎓Education:

Prof. Dmitry Dar’in has pursued an extensive educational journey focused on chemistry, culminating in his expertise in heterocyclic compounds and organic synthesis. He completed his initial studies at a reputed university, where he laid a strong foundation in chemical theory and application. Further advancing his knowledge, Prof. Dar’in specialized in heterocyclic and diazo chemistry, undertaking advanced research projects and collaborative studies that have become foundational to his career. His formal education was complemented by ongoing research, allowing him to gain hands-on experience with complex chemical reactions and synthesis methodologies. Prof. Dar’in has continued his professional development through interactions with prominent research groups worldwide, which have enriched his teaching and research endeavors. His education paved the way for his current role as a professor and researcher, where he imparts deep knowledge in organic synthesis and continues to explore innovative approaches in chemistry.

🏢Work Experience:

With over two decades of experience in academic and applied research, Prof. Dmitry Dar’in has established himself as a leader in heterocyclic chemistry and diazo compound synthesis. He teaches advanced courses on heterocyclic chemistry and organic synthesis at Saint Petersburg State University, where he has also supervised over 20 graduate theses, guiding students in cutting-edge research methodologies. Prof. Dar’in’s experience spans multiple successful projects, including five current research endeavors and two consultancy projects for industry partners. His expertise is further reflected in his role as Guest Editor for Molecules, where he oversees specialized issues on diazo chemistry. Prof. Dar’in has extensive international collaboration experience, working closely with esteemed scientists like Prof. Ewgenij Proschak and Prof. Saeed Balalaie. His global engagements and dedication to advancing chemistry research continue to influence modern synthetic methods and applications, particularly in medicinal chemistry and targeted protein degradation.

🏅Awards:

Prof. Dmitry Dar’in has received several prestigious awards in recognition of his innovative contributions to chemistry, particularly in the areas of heterocyclic compounds and diazo chemistry. His groundbreaking work has earned him the respect of both academic and industrial circles, where his methods for synthesizing diazo compounds in aqueous environments and his contributions to the Castagnoli-Cushman reaction have been particularly celebrated. His scholarly excellence is also recognized through his editorial role for Molecules, showcasing his influence in shaping modern research directions. In addition to these honors, Prof. Dar’in has been acknowledged for his collaborative work with international research leaders, reflecting his commitment to global scientific advancement. His contributions to the field, both in education and research, have earned him nominations for top-tier awards such as the Best Researcher Award, emphasizing his stature as a leading scientist in organic synthesis and multicomponent reactions.

🔬Research Focus:

Prof. Dmitry Dar’in’s research primarily explores diazo chemistry, heterocyclic compounds, and multicomponent reactions. He has pioneered efficient synthesis methods for diazo compounds, especially diazo metanesulfonamides, and has introduced aqueous medium diazo transfer techniques, which have expanded the practical applications of these compounds. His work with polysubstituted lactams through the Castagnoli-Cushman reaction has unlocked new pathways for using cyclic anhydrides and imine-type reagents. Prof. Dar’in’s research also delves into targeted protein degradation, trace amine-associated receptors, and antitubercular agents, making substantial strides in medicinal chemistry. His innovative approaches to synthesizing five- and six-membered diazo heterocycles have opened avenues for further exploration in core functionalization and heterocyclic frameworks. Prof. Dar’in’s research remains at the forefront of organic chemistry, impacting both theoretical knowledge and practical applications in pharmaceutical sciences.

Publication Top Notes:

  • Title: Synthesis of cyclic sulfamides via one-pot alkylation/aza-Michael cascade reaction
  • Title: Coinage (Au, Ag, Cu) metal-catalyzed (3 + 2) annulation of α-aminoketones and electron-deficient alkynes as a route to 3-EWG-substituted pyrroles
    • Citations: 1
  • Title: Diazo Tetramic Acids Provide Access to Natural-Like Spirocyclic Δα,β-Butenolides through Rh(II)-Catalyzed O-H Insertion/Base-Promoted Cyclization
    • Citations: 6
  • Title: The synthesis of 1-oxa-9-azaspiro[5.5]undecane derivatives and optimization of antituberculosis activity thereof
  • Title: Phosphorescent Cyclometalated Palladium(II) and Platinum(II) Complexes Derived from Diaminocarbene Precursors